Analysts expect AMETEK, Inc. (NYSE:AME) to announce earnings of $0.72 per share for the current fiscal quarter, according to Zacks. Seven analysts have provided estimates for AMETEK’s earnings, with estimates ranging from $0.70 to $0.73. AMETEK reported earnings per share of $0.60 in the same quarter last year, which suggests a positive year-over-year growth rate of 20%. The firm is scheduled to report its next quarterly earnings results before the market opens on Wednesday, May 2nd.
On average, analysts expect that AMETEK will report full year earnings of $3.05 per share for the current fiscal year, with EPS estimates ranging from $3.00 to $3.12. For the next financial year, analysts expect that the firm will report earnings of $3.34 per share, with EPS estimates ranging from $3.25 to $3.42. Zacks’ earnings per share calculations are an average based on a survey of research analysts that that provide coverage for AMETEK.
AMETEK (NYSE:AME) last released its quarterly earnings data on Thursday, February 1st. The technology company reported $0.70 EPS for the quarter, beating the Thomson Reuters’ consensus estimate of $0.67 by $0.03. The business had revenue of $1.14 billion for the quarter, compared to the consensus estimate of $1.09 billion. AMETEK had a net margin of 15.85% and a return on equity of 16.39%. The company’s revenue was up 17.5% compared to the same quarter last year. During the same period in the prior year, the firm earned $0.58 earnings per share.
Several equities research analysts have commented on AME shares. KeyCorp reaffirmed a “buy” rating and set a $82.00 price objective on shares of AMETEK in a report on Friday, January 19th. Wells Fargo set a $88.00 price objective on shares of AMETEK and gave the company a “buy” rating in a report on Thursday, January 18th. Zacks Investment Research raised shares of AMETEK from a “hold” rating to a “buy” rating and set a $82.00 price objective on the stock in a report on Thursday, January 4th. BMO Capital Markets reaffirmed a “buy” rating and set a $88.00 price objective on shares of AMETEK in a report on Friday, January 26th. Finally, DA Davidson assumed coverage on shares of AMETEK in a report on Thursday, April 12th. They set a “buy” rating and a $85.00 price objective on the stock. Two research analysts have rated the stock with a hold rating and twelve have assigned a buy rating to the company. The company has an average rating of “Buy” and a consensus target price of $81.58.
NYSE AME traded down $0.72 during trading on Friday, hitting $75.81. 1,349,710 shares of the company’s stock traded hands, compared to its average volume of 884,796. The company has a market cap of $17,537.51, a PE ratio of 29.05, a price-to-earnings-growth ratio of 2.48 and a beta of 1.24. AMETEK has a 12-month low of $54.76 and a 12-month high of $79.32. The company has a quick ratio of 1.22, a current ratio of 1.70 and a debt-to-equity ratio of 0.46.
The company also recently declared a quarterly dividend, which was paid on Thursday, March 29th. Stockholders of record on Friday, March 16th were issued a $0.14 dividend. This represents a $0.56 dividend on an annualized basis and a dividend yield of 0.74%. This is an increase from AMETEK’s previous quarterly dividend of $0.09. The ex-dividend date of this dividend was Thursday, March 15th. AMETEK’s dividend payout ratio is presently 21.46%.
In related news, Director Elizebeth R. Varet sold 6,295 shares of the firm’s stock in a transaction that occurred on Wednesday, February 7th. The shares were sold at an average price of $74.72, for a total value of $470,362.40. The sale was disclosed in a filing with the SEC, which is available through this link. Also, VP William D. Eginton sold 16,368 shares of the firm’s stock in a transaction that occurred on Monday, February 5th. The shares were sold at an average price of $77.00, for a total transaction of $1,260,336.00. Following the completion of the sale, the vice president now directly owns 59,054 shares in the company, valued at $4,547,158. The disclosure for this sale can be found here. Over the last three months, insiders sold 77,604 shares of company stock worth $5,976,638. Insiders own 2.10% of the company’s stock.
A number of institutional investors and hedge funds have recently made changes to their positions in AME. American Century Companies Inc. raised its stake in AMETEK by 42.5% in the fourth quarter. American Century Companies Inc. now owns 4,067,798 shares of the technology company’s stock valued at $294,793,000 after purchasing an additional 1,214,153 shares in the last quarter. BlackRock Inc. raised its stake in AMETEK by 6.2% in the fourth quarter. BlackRock Inc. now owns 15,074,188 shares of the technology company’s stock valued at $1,092,426,000 after purchasing an additional 886,625 shares in the last quarter. Allianz Asset Management GmbH raised its stake in AMETEK by 28.2% in the fourth quarter. Allianz Asset Management GmbH now owns 3,095,683 shares of the technology company’s stock valued at $224,343,000 after purchasing an additional 681,646 shares in the last quarter. Millennium Management LLC raised its stake in AMETEK by 154.3% in the fourth quarter. Millennium Management LLC now owns 782,344 shares of the technology company’s stock valued at $56,696,000 after purchasing an additional 474,712 shares in the last quarter. Finally, Strs Ohio raised its stake in AMETEK by 447.0% in the fourth quarter. Strs Ohio now owns 392,395 shares of the technology company’s stock valued at $28,436,000 after purchasing an additional 320,660 shares in the last quarter. 85.81% of the stock is currently owned by institutional investors and hedge funds.
TRADEMARK VIOLATION WARNING: This piece of content was first published by Dispatch Tribunal and is owned by of Dispatch Tribunal. If you are viewing this piece of content on another site, it was stolen and reposted in violation of US and international copyright law. The original version of this piece of content can be viewed at https://www.dispatchtribunal.com/2018/04/22/brokerages-anticipate-ametek-inc-ame-to-announce-0-72-earnings-per-share.html.
AMETEK, Inc manufactures and sells electronic instruments and electromechanical devices worldwide. Its Electronic Instruments Group segment offers advanced instruments for the process, power and industrial, and aerospace markets; process and analytical instruments for the oil, gas, petrochemical, pharmaceutical, semiconductor, automation, and food and beverage markets; and instruments for the laboratory equipment, ultraprecision manufacturing, medical, and test and measurement markets.
Get a free copy of the Zacks research report on AMETEK (AME)
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for AMETEK Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for AMETEK and related companies with MarketBeat.com's FREE daily email newsletter.